Ethnobotanical medicine potential Lyme disease treatment
Some plant-based herbal medicines, such as Ghanaian quinine and Japanese knotweed, work better than antibiotics for targeting bacterium causing Lyme disease, according to a new preclinical study published in Frontiers in Medicine.
Lyme disease, also called borreliosis, is the most common vector-borne disease in the Northern hemisphere. It is caused by the spirochete bacterium Borrelia burgdorferi and close relatives and mainly spread through the bite of infected ticks.
Currently, more than 300,000 new cases are reported in the United States each year, compared to 65,000 in Europe, and these numbers are rising due to climate change and urban sprawl. The standard of care for Lyme disease, a course of antibiotics over two to four weeks, is not always effective, researchers said. At least 10 to 20 percent of treated patients continue to experience symptoms after treatment.
Late-stage Lyme patients may experience many different symptoms, including fatigue, joint pains, memory problems, facial paralysis, aches, stiffness in the neck, heart palpitations, and severe headaches. The discovery of novel treatments against Lyme disease is therefore of great interest, the researchers said in a statement.
Researchers from the Johns Hopkins Bloomberg School of Public Health, with colleagues at the California Center for Functional Medicine and Focus Health, surveyed the power of 14 plant-based extracts to kill Borrelia burgdorferi, compared to the currently used Lyme antibiotics doxycycline and cefuroxime.
The researchers tested these extracts' effectiveness in vitro against the free-swimming "planktonic" form of the bacterium as well as against microcolonies. Microcolonies are aggregates of bacteria, the first stage in the development of biofilms - structured bacterial communities that stick to a surface and are embedded in a slimy extracellular matrix.
The researchers show that plant extracts from black walnut, cat's claw, sweet wormwood, Mediterranean rockrose, and Chinese skullcap had strong activity against B. burgdorferi, outperforming both tested antibiotics. But by far the strongest performers were Ghanaian quinine, Cryptolepis sanguinolenta, also known as yellow-dye root, nibima, or kadze; and Japanese knotweed, Polygonum cuspidatum.
Ghanaian quinine is a shrub from West Africa containing the antimicrobial alkaloid cryptolepine, and is used in ethnomedicine to treat malaria, hepatitis, septicemia, and tuberculosis. Japanese knotweed is a traditional medicine in India and China that contains the polyphenol resveratrol. In other preclinical studies it has been found to have anti-tumor and anti-inflammatory effects and protect the nervous system and heart.
Extracts from both plants were found to kill microcolonies of Borrelia burgdorferi and inhibit division of the planktonic form, even at low concentrations of 0.03-0.5 percent. Remarkably, a single seven-day treatment with 1 percent Ghanaian quinine could completely eradicate the bacterium.
"This study provides the first convincing evidence that some of the herbs used by patients such as Cryptolepis, black walnut, sweet wormwood, cat's claw, and Japanese knotweed have potent activity against Lyme disease bacteria, especially the dormant persister forms, which are not killed by the current Lyme antibiotics," said Ying Zhang, MD, lead author of the study and faculty director at the Johns Hopkins Bloomberg School of Public Health, in a statement.
However, not all tested compounds or herbs yielded positive results against the bacterium. Extracts of grapefruit seeds, green chiretta, ashwagandha, candy leaf or stevia, fuller's teasel, and Japanese teasel had little or no effect, and neither did the chemicals colloidal silver, monoglyceride monolaurin, or antimicrobial peptide LL37 from human immune cells. This was surprising, as anecdotal and preclinical studies suggested that they might be effective, and they are often used in the community of Lyme disease practitioners and patients, Zhang said.
“These findings are exciting as they offer opportunities for improved treatment of persistent Lyme disease, which is not helped by the current standard treatment,” said Zhang. “We are interested in further evaluating these potent herbal medicines through animal studies as well as clinical trials.”